SBIR Phase I: Surgical Closure Device

点击翻译按钮获取中文摘要

This Small Business Innovation Research (SBIR) Phase I project develops a novel surgical closure system for closing internal incisions in endoscopy. The initial application is closing the vaginal cuff in laparoscopic hysterectomy. Sutures are typically used to close internal incisions in laparoscopic surgery. Throwing loops and tying knots are among the most difficult parts of laparoscopic procedures; these difficulties have slowed the adoption of minimally-invasive procedures, including laparoscopic hysterectomy. The system is a series of surgical clips that are designed to enable easy closure for difficult-to-access tissue, improving ease of use, speed, and quality of incision closure. The clips do not pierce tissue, but apply continuous compression to close the incision. The applicator tool pulls tissue into apposition for clip application, while reducing tissue handling, necrosis, ischemia, and the risk of infection. The broader impact/commercial potential of this project is to develop, validate, and market the device across a broad spectrum of surgeries involving internal incisions (a total of 10 million procedures annually in the U.S. alone). This device has particular value in the rapidly-growing minimally-invasive surgery market, in which internal closure is made difficult by the small size of superficial incisions. These markets represent more than 6 million surgeries per year in the U.S., creating a domestic market potential of more than $2.5 billion for the device platform of closure devices. The closure device is designed to be simple and intuitive to use, which is critical in laparoscopic procedures. Initially, the closure device directly addresses a specific unmet clinical need: reducing both the technical demands of vaginal cuff closure during laparoscopic hysterectomy and the significant complications associated with the use of sutures in this procedure. There are approximately 300,000 laparoscopic hysterectomies performed in the U.S. annually. This number is growing at an estimated rate of 20% per year, and will represent a total annual addressable domestic market size at peak sales of $200 MM ($600 MM globally) for laparoscopic hysterectomy alone.